Progress of diagnosis and treatment of intrahepatic cholangiocarcinoma
10.3760/cma.j.issn.1673-4203.2020.02.013
- VernacularTitle: 肝内胆管细胞癌的诊断及治疗方法研究进展
- Author:
Mingyou XU
1
;
Peng XIE
1
Author Information
1. Department of Hepatobiliary Surgery, Wanbei Coal-Electricity Group General Hospital, Suzhou 234100, China
- Publication Type:Review
- Keywords:
Bile duct neoplasms;
Diagnosis;
Therapeutic uses;
Introhepatic cholangiocarcinoma
- From:
International Journal of Surgery
2020;47(2):130-134
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of intrahepatic cholangiocarcinoma (ICC) is increasing year by year, and the cause of its onset is still not clear. Enhanced CT or enhanced magnetic resonance imaging is a commonly used diagnostic method, and postoperative pathology inspection is the most important criterion for diagnosis. The overall therapeutic effect of ICC is not satisfactory. Surgical resection is the only curative treatment. However, the low resection rate and high recurrence rate are difficult treatments for the disease. This article reviews the etiology, diagnosis and treatment of ICC.